A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma
出版年份 2018 全文链接
标题
A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma
作者
关键词
-
出版物
CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-12-07
DOI
10.1002/cncr.31907
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy
- (2018) Baomin Zheng et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunotherapy for Pancreatic Cancer: More Than Just a Gut Feeling
- (2018) Erick Riquelme et al. Cancer Discovery
- Killing Effects of an Isolated Serratia marcescens KH-001 on Diaphorina citri via Lowering the Endosymbiont Numbers
- (2018) Wei Hu et al. Frontiers in Microbiology
- Gut microbes shape response to cancer immunotherapy
- (2017) Jocelyn Kaiser SCIENCE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma
- (2016) Guopei Zhu et al. BMC CANCER
- Microbiome and Anticancer Immunosurveillance
- (2016) Laurence Zitvogel et al. CELL
- Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
- (2016) Ying Sun et al. LANCET ONCOLOGY
- Development of immuno-oncology drugs — from CTLA4 to PD1 to the next generations
- (2016) Axel Hoos NATURE REVIEWS DRUG DISCOVERY
- Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
- (2016) Xin Fang et al. Frontiers in Microbiology
- CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines
- (2015) Charlotte L. Brouwer et al. RADIOTHERAPY AND ONCOLOGY
- Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies
- (2015) Alexander M.M. Eggermont et al. SEMINARS IN ONCOLOGY
- Microbiota and their role in the pathogenesis of oral mucositis
- (2014) B Vanhoecke et al. ORAL DISEASES
- How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?
- (2014) Ole Audun Werner Haabeth et al. Frontiers in Immunology
- Changes of saliva microbiota in nasopharyngeal carcinoma patients under chemoradiation therapy
- (2013) Yuan Xu et al. ARCHIVES OF ORAL BIOLOGY
- Reciprocal interactions of the intestinal microbiota and immune system
- (2012) Craig L. Maynard et al. NATURE
- Interactions Between the Microbiota and the Immune System
- (2012) L. V. Hooper et al. SCIENCE
- Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study
- (2011) Atul Sharma et al. EUROPEAN JOURNAL OF CANCER
- Rifaximin diminishes neutropenia following potentially lethal whole-body radiation
- (2011) Christopher D Jahraus et al. EXPERIMENTAL BIOLOGY AND MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search